title: Endothelial growth factor receptor inhibition after radiotherapy.
authors.affiliation: Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy. giovannini.monica@hsr.it
authors.forename: Monica
authors.initials: M
authors.lastname: Giovannini
authors.forename: Vanesa
authors.initials: V
authors.lastname: Gregorc
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Viganò
authors.forename: Anna
authors.initials: A
authors.lastname: Spreafico
authors.forename: Domenico
authors.initials: D
authors.lastname: Ghio
authors.forename: Italo
authors.initials: I
authors.lastname: Dell'Oca
authors.forename: Angelo
authors.initials: A
authors.lastname: Bolognesi
authors.forename: Eugenio
authors.initials: E
authors.lastname: Villa
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000037:antagonists & inhibitors / Q000097:blood; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood / Q000188:drug therapy / Q000532:radiotherapy; D005500:Follow-Up Studies; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use*; D011832:Radiation Injuries / Q000188:drug therapy / Q000473:pathology; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors* / Q000097:blood; D012867:Skin / Q000473:pathology / Q000528:radiation effects
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D011799:Quinazolines; D040262:Receptors, Vascular Endothelial Growth Factor; D000077156:Gefitinib